WELL Health Technologies Corp. (TSX:WELL)
Canada flag Canada · Delayed Price · Currency is CAD
4.480
-0.070 (-1.54%)
Jun 15, 2026, 4:00 PM EST

WELL Health Technologies Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, WELL Health Technologies stock has a consensus rating of "Buy" and an average price target of $7.03. The average 1-year stock price forecast is 56.92% higher than the current stock price, while the lowest is $5.00 (+11.61%) and the highest is $8.25 (+84.15%).

Price Target: $7.03 (+56.92%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$5.00$7.03$7.00$8.25
Change+11.61%+56.92%+56.25%+84.15%

Analyst Ratings

The average analyst rating for WELL Health Technologies stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy887777
Buy655555
Hold011111
Sell000000
Strong Sell000000
Total141413131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
TD Cowen
No rating
TD Cowen
Buy
Maintains
$7.00
BuyMaintains$7.00+56.25%Jun 4, 2026
CIBC
CIBC
Buy
Reiterates
$5.50$6.00
BuyReiterates$5.50$6.00+33.93%Jun 3, 2026
Haywood
Haywood
Buy
Maintains
$8.00
BuyMaintains$8.00+78.57%Jun 3, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$8.25
BuyMaintains$8.25+84.15%Jun 2, 2026
Ventum Financial
Ventum Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.58B
from 1.40B
Increased by 13.07%
Revenue Next Year
1.69B
from 1.58B
Increased by 6.99%
EPS This Year
0.27
from 0.49
Decreased by -44.66%
EPS Next Year
0.38
from 0.27
Increased by 40.18%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
302.32M569.14M776.05M919.69M1.40B1.58B
Revenue Growth
501.76%88.25%36.36%18.51%52.25%13.07%
Gross Profit
153.70M303.29M372.27M363.01M618.84M689.58M
Gross Margin
50.84%53.29%47.97%39.47%44.20%43.56%
Operating Income
1.46M33.08M34.52M-29.86M93.59M61.04M
Net Income
-44.18M1.37M82.00K32.61M-7.36M-31.17M
EPS
----0.490.27
EPS Growth
----1,533.33%-44.66%
Forward PE
---226.4041.9616.52
Free Cash Flow
-676.63K72.09M31.13M200.21M-28.69M89.95M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue202620272028
High1.6B
Avg1.6B
Low1.5B

Revenue Growth

Revenue Growth202620272028
High
16.8%
Avg
13.1%
Low
8.6%

EPS Forecast

EPS202620272028
High0.39
Avg0.27
Low0.17

EPS Growth

EPS Growth202620272028
High
-20.4%
Avg
-44.7%
Low
-65.3%